The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Nutrient regulation of signaling and transcription
Open accessAbstract
In the early 1980s, while using purified glycosyltransferases to probe glycan structures on surfaces of living cells in the murine immune system, we discovered a novel form of serine/threonine protein glycosylation (O-linked -GlcNAc; O-GlcNAc) that occurs on thousands of proteins within the nucleus, cytoplasm, and mitochondria.Prior to this discovery, it was dogma that protein glycosylation was restricted to the luminal compartments of the secretory pathway and on extracellular domains of membrane and secretory proteins.Work in the last 3 decades from several laboratories has shown that O-GlcNAc cycling serves as a nutrient sensor to regulate signaling, transcription, mitochondrial activity, and cytoskeletal functions.O-GlcNAc also has extensive cross-talk with phosphorylation, not only at the same or proximal sites on polypeptides, but also by regulating each other's enzymes that catalyze cycling of the modifications.O-GlcNAc is generally not elongated or modified.It cycles on and off polypeptides in a time scale similar to phosphorylation, and both the enzyme that adds O-GlcNAc, the O-GlcNAc transferase (OGT), and the enzyme that removes O-GlcNAc, O-GlcNAcase (OGA), are highly conserved from C. elegans to humans.Both O-GlcNAc cycling enzymes are essential in mammals and plants.Due to O-GlcNAc's fundamental roles as a nutrient and stress sensor, it plays an important role in the etiologies of chronic diseases of aging, including diabetes, cancer, and neurodegenerative disease.This review will present an overview of our current understanding of O-GlcNAc's regulation, functions, and roles in chronic diseases of aging.This work was supported
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–333 of 333
Jensen, R. V., Zachara, N. E., Nielsen, P. H., Kimose, H., Kristiansen, S. B., & Bøtker, H. E. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs337 · Cited by 100
Brister, M., Pandey, A. K., Bielska, A. A., & Zondlo, N. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja407156m · Cited by 100
Phosphorylation and Glycosylation of Nucleoporins
Miller, M. W., Caracciolo, M. R., Berlin, W. K., & Hanover, J. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1237 · Cited by 100
Yehezkel, G., Cohen, L., Kliger, A., Manor, E., & Khalaila, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345546 · Cited by 100
Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode
Li, B., Li, H., Lü, L., & Jiang, J. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3390 · Cited by 100
Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Leszek, J., Trypka, E., Tarasov, V. V., Ashraf, G. M., & Aliev, G. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170103163403 · Cited by 96
Deng, Y., Li, B., Liu, F., Iqbal, K., Grundke, I., Brandt, R., & Gong, C. (2007) · The FASEB Journal · doi:10.1096/fj.07-8309com · Cited by 95
O-GlcNAc transferase inhibitors: current tools and future challenges
Trapannone, R., Rafie, K., & van Aalten, D. M. F. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150189 · Cited by 95
O-GlcNAc modification of PPARγ reduces its transcriptional activity
Ji, S., Park, S., Roth, J., Kim, H. S., & Cho, J. W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.086 · Cited by 94
Xie, S.-T., Jin, N., Gu, J., Shi, J., Sun, J., Chu, D., Zhang, L. N., Dai, C., Gu, J., Gong, C., et al. (2016) · Aging Cell · doi:10.1111/acel.12449 · Cited by 94
Stichelen, S. O.-V., Guinez, C., Mir, A., Pérez-Cervera, Y., Liu, C., Michalski, J., & Lefebvre, T. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2011 · Cited by 93
O-GlcNAcylation regulates ischemia-induced neuronal apoptosis through AKT signaling
Shi, J., Gu, J., Dai, C., Gu, J., Jin, X., Sun, J., Iqbal, K., Liu, F., & Gong, C. (2015) · Scientific Reports · doi:10.1038/srep14500 · Cited by 93
Protein O-GlcNAcylation and Cardiovascular (Patho)physiology
Marsh, S. A., Collins, H. E., & Chatham, J. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.585984 · Cited by 92
A Subpopulation of Estrogen Receptors Are Modified by O-Linked N-Acetylglucosamine
Jiang, M.-S., & Hart, G. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2421 · Cited by 88
Self-citationComparative Proteomics Reveals Dysregulated Mitochondrial O-GlcNAcylation in Diabetic Hearts
Ma, J., Banerjee, P., Whelan, S. A., Liu, T., Wei, A., Ramirez‐Correa, G. A., McComb, M. E., Costello, C. E., O'Rourke, B. P., Murphy, A. M., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00250 · Cited by 88
Self-citationStarr, C. M., & Hanover, J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39229-4 · Cited by 87
Aguilar, H., Fricovsky, E. S., Ihm, S., Schimke, M., Maya-Ramos, L., Aroonsakool, N., Ceballos, G. M., DILLMANN, W. H., Villarreal, F. J., & Ramírez‐Sánchez, I. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00251.2013 · Cited by 87
Chen, Y., Du, J., Zhou, L., Liu, X.-H., Zhao, Y., Nakanishi, H., & Li, Y. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.06.017 · Cited by 86
O-Linked N-Acetylglucosamine Modification on CCAAT Enhancer-binding Protein β
Li, X., Molina, H., Huang, H., Zhang, Y.-Y., Liu, M., Qian, S.-W., Slawson, C. M., Dias, W. B., Pandey, A., Hart, G. W., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005678 · Cited by 85
Self-citationMyers, S. A., Peddada, S., Chatterjee, N., Friedrich, T., Tomoda, K., Krings, G., Thomas, S., Maynard, J. C., Broeker, M., Thomson, M., et al. (2016) · eLife · doi:10.7554/elife.10647 · Cited by 85
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line
Lefebvre, T., Alonso, C., Mahboub, S., Dupire, M.-J., Zanetta, J., Caillet‐Boudin, M., & Michalski, J. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00105-1 · Cited by 84
Song, M., Kim, H.-S., Park, J.-M., Kim, S.-H., Kim, I.-H., Ryu, S. H., & Suh, P. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.09.002 · Cited by 84
Arabidopsis O‐GlcNAc transferase SEC activates histone methyltransferase ATX1 to regulate flowering
Xing, L., Liu, Y., Xu, S., Xiao, J. Y., Wang, B., Deng, H., Lu, Z., Xu, Y., & Chong, K. (2018) · The EMBO Journal · doi:10.15252/embj.201798115 · Cited by 84
Giaccari, A., Morviducci, L., Zorretta, D., Sbraccia, P., Leonetti, F., Caiola, S., Buongiorno, A. M., Bonadonna, R. C., & TAMBURRANO, G. (1995) · Diabetologia · doi:10.1007/bf00400719 · Cited by 83
The role of O ‐GlcNAc signaling in the pathogenesis of diabetic retinopathy
Semba, R. D., Hu, H., Lutty, G. A., Eyk, J. E. V., & Hart, G. W. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300076 · Cited by 81
Self-citationKuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.005 · Cited by 81
The roles ofO-linked β-N-acetylglucosamine in cardiovascular physiology and disease
Zachara, N. E. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00445.2011 · Cited by 81
Ido-Kitamura, Y., Sasaki, T., Kobayashi, M., Kim, H., Lee, Y., Kikuchi, O., Yokota‐Hashimoto, H., Iizuka, K., Accili, D., & Kitamura, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047231 · Cited by 81
Park, K., Saudek, C. D., & Hart, G. W. (2010) · Diabetes · doi:10.2337/db09-1086 · Cited by 81
Self-citationGreis, K. D., Gibson, W., & Hart, G. W. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8339-8349.1994 · Cited by 80
Self-citationMechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes
Gloster, T. M., & Vocadlo, D. J. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210790226537 · Cited by 80
Characterisation of human N‐acetyl‐β‐hexosaminadase C
Braidman, I. P., Carroll, M., Dance, N., & Robinson, D. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)81206-8 · Cited by 80
The emerging link between O-GlcNAcylation and neurological disorders
Ma, X., Li, H., He, Y., & Hao, J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2542-9 · Cited by 80
Myers, S. A., Daou, S., Affar, E. B., & Burlingame, A. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201200332 · Cited by 79
O-GlcNAcylation of Cofilin Promotes Breast Cancer Cell Invasion
Huang, X., Pan, Q., Sun, D., Chen, W., Shen, A., Huang, M., Ding, J., & Geng, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.495713 · Cited by 78
Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer
Phueaouan, T., Chaiyawat, P., Netsirisawan, P., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., Svasti, J., & Champattanachai, V. (2013) · Oncology Reports · doi:10.3892/or.2013.2794 · Cited by 78
Akimoto, Y., Kreppel, L. K., Hirano, H., & Hart, G. W. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2331 · Cited by 77
Self-citationSohn, K., Lee, K., Park, J. E., & Do, S.-I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.023 · Cited by 75
Juang, Y., Solomou, E. E., Rellahan, B. L., & Tsokos, G. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2865 · Cited by 75
O-Linked N-Acetylglucosamine and Cancer: Messages from the Glycosylation of C-Myc
Chou, T., & Hart, G. W. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1267-7_26 · Cited by 74
Self-citationPalmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes
Weigert, C., Klopfer, K., Kausch, C., Brodbeck, K., Stümvoll, M., Häring, H. U., & Schleicher, E. D. (2003) · Diabetes · doi:10.2337/diabetes.52.3.650 · Cited by 74
Vanderford, N. L., Andrali, S. S., & Özcan, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605064200 · Cited by 73
Hexosamines Regulate Leptin Production in Human Subcutaneous Adipocytes
Considine, R. V., Cooksey, R. C., Williams, L. B., Fawcett, R. L., Zhang, P., Ambrosius, W. T., Whitfield, R. M., Jones, R., Inman, M. M., Huse, J., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6916 · Cited by 73
O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon
Majumdar, G., Harmon, A., Candelaria, R. P., Martinez-Hernandez, A., Raghow, R., & Solomon, S. S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00140.2003 · Cited by 73
O-GlcNAcase: Promiscuous Hexosaminidase or Key Regulator of O-GlcNAc Signaling?
Alonso, J., Schimpl, M., & van Aalten, D. M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.609198 · Cited by 72
Skorobogatko, Y. V., Landicho, A., Chalkley, R. J., Kossenkov, A. V., Gallo, G., & Vosseller, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512814 · Cited by 72
Nagel, A. K., & Ball, L. E. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.040691 · Cited by 71
Jiang, M., Yu, S., Yu, Z., Sheng, H., Li, Y., Liu, S., Warner, D. S., Paschen, W., & Yang, W. (2017) · Stroke · doi:10.1161/strokeaha.117.016579 · Cited by 71
Alzheimer's disease could be “type 3 diabetes”
Pilcher, H. R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70434-3 · Cited by 70
Lewis, B. A., Burlingame, A. L., & Myers, S. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684365 · Cited by 70
Kanwal, S., Fardini, Y., Pagésy, P., N’Tumba-Byn, T., Pierre‐Eugène, C., Masson, E., Hampe, C., & Issad, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069150 · Cited by 69
Gatta, E., Lefebvre, T., Gaetani, S., Santos, M. D., Marrocco, J., Mir, A., Cassano, T., Maccari, S., Nicoletti, F., & Mairesse, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.006 · Cited by 69
O‐GlcNAc Modification Prevents Peptide‐Dependent Acceleration of α‐Synuclein Aggregation
Marotta, N. P., Cherwien, C. A., Abeywardana, T., & Pratt, M. R. (2012) · ChemBioChem · doi:10.1002/cbic.201200478 · Cited by 68
Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine.
Benko, D. M., Haltiwanger, R. S., Hart, G. W., & Gibson, W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2573 · Cited by 66
Self-citationStructural insights into the substrate binding adaptability and specificity of human O-GlcNAcase
Li, B., Li, H., Hu, C., & Jiang, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00865-1 · Cited by 65
My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy
Brahma, M. K., Pepin, M. E., & Wende, A. R. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.1.1 · Cited by 64
Ha, J. R., Hao, L., Venkateswaran, G., Huang, Y., Garcia, E., & Persad, S. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.11.021 · Cited by 62
Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer
Chaiyawat, P., Netsirisawan, P., Svasti, J., & Champattanachai, V. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00193 · Cited by 60
O-GlcNAc transferase regulates transcriptional activity of human Oct4
Constable, S., Lim, J., Vaidyanathan, K., & Wells, L. (2017) · Glycobiology · doi:10.1093/glycob/cwx055 · Cited by 60
Chun, Y. S., Kwon, O.-H., & Chung, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.067 · Cited by 60
Regulation of Akt signaling byO-GlcNAc in euglycemia
Soesanto, Y., Luo, B., Jones, D., Taylor, R. P., Gabrielsen, J. S., Parker, G. J., & McClain, D. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90366.2008 · Cited by 59
Schultz, J., & Pils, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03322-7 · Cited by 58
Role ofO-linkedN-acetylglucosamine modification in diabetic nephropathy
Gellai, R., Hodrea, J., Lénárt, L., Hosszú, Á., Kőszegi, S., Balogh, D. B., Vér, Á., Bánki, N. F., Fülöp, N., Molnár, Á., et al. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00545.2015 · Cited by 58
Molecular mechanisms of O-GlcNAcylation
Hurtado-Guerrero, R., Dorfmueller, H. C., & van Aalten, D. M. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.09.005 · Cited by 57
Increased O-GlcNAc transferase in pancreas of rats with streptozotocin-induced diabetes
Akimoto, Y., Kreppel, L. K., Hirano, H., & Hart, G. W. (2000) · Diabetologia · doi:10.1007/s001250051519 · Cited by 57
Self-citationLi, H., Liu, X., Wang, D., Su, L., Zhao, T., Li, Z., Lin, C., Zhang, Y., Huang, B., Lü, J., et al. (2017) · Scientific Reports · doi:10.1038/srep43601 · Cited by 57
Kim, S.-J., Yoo, W.-S., Choi, M.-Y., Chung, I. Y., Yoo, J.-M., & Choi, W.-S. (2015) · Current Eye Research · doi:10.3109/02713683.2015.1006372 · Cited by 56
Delineation of the dystonia-parkinsonism syndrome locus in Xq13.
Graeber, M. B., Kupke, K. G., & Müller, U. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8245 · Cited by 55
Evidence of O-linked N-acetylglucosamine in diabetic nephropathy
Degrell, P., Cseh, J., Mohás, M., Molnár, G. A., Pajor, L., Chatham, J. C., Fülöp, N., & Wittmann, I. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.01.007 · Cited by 54
O-GlcNAc modification of nucleocytoplasmic proteins and diabetes
Akimoto, Y., Hart, G. W., Hirano, H., & Kawakami, H. (2005) · Medical Molecular Morphology · doi:10.1007/s00795-004-0264-1 · Cited by 54
Self-citationThe E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc
Wells, L., Slawson, C. M., & Hart, G. W. (2010) · Amino Acids · doi:10.1007/s00726-010-0709-x · Cited by 54
Self-citationO-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma
Bachmaier, R., Aryee, D. N. T., Jug, G., Kauer, M. O., Kreppel, M., Lee, K. A. W., & Kovar, H. (2009) · Oncogene · doi:10.1038/onc.2008.484 · Cited by 53
Chalkley, R. J., & Burlingame, A. L. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300027-mcp200 · Cited by 53
Nagel, A. K., & Ball, L. E. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.12.003 · Cited by 52
Liu, Q., Tao, T., Liu, F., Ni, R., Lu, C., & Shen, A. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.10.011 · Cited by 50
Hexosamines Regulate Leptin Production in Human Subcutaneous Adipocytes
Considine, R. V. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3551 · Cited by 50
Robles‐Flores, M., Meléndez, L., García, W., Mendoza‐Hernández, G., Lam, T. T., Castañeda‐Patlán, M. C., & González-Aguilar, H. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.07.011 · Cited by 49
Excessive O‐GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells
Kim, H.-S., Park, S., Choi, Y. R., Kang, J. G., Joo, H. J., Moon, W. K., & Cho, J. W. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.052 · Cited by 49
Liu, S., Sheng, H., Yu, Z., Paschen, W., & Yang, W. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15608393 · Cited by 49
O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein
Levine, P. M., Leon, C. A. D., Galesic, A., Balana, A. T., Marotta, N. P., Lewis, Y. E., & Pratt, M. R. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.04.038 · Cited by 49
O-Linked N -Acetylglucosaminylation of Sp1 Inhibits the Human Immunodeficiency Virus Type 1 Promoter
Jochmann, R., Thurau, M., Jung, S., Hofmann, C., Naschberger, E., Kremmer, E., Harrer, T., Miller, M., Schaft, N., & Stürzl, M. (2009) · Journal of Virology · doi:10.1128/jvi.01384-08 · Cited by 48
Gürel, Z., & Sheibani, N. (2018) · Clinical Science · doi:10.1042/cs20171454 · Cited by 48
Akimoto, Y., Kawakami, H., Yamamoto, K., Munetomo, E., Hida, T., & Hirano, H. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0227 · Cited by 47
OGT: a short overview of an enzyme standing out from usual glycosyltransferases
Aquino-Gil, M. O., Pierce, A., Pérez-Cervera, Y., Zenteno, E., & Lefebvre, T. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160404 · Cited by 47
Tsokos, G. C., Nambiar, M. P., & Juang, Y. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06054.x · Cited by 46
Han, I., Oh, E., & Kudlow, J. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500109 · Cited by 46
O-GlcNAc expression in developing and ageing mouse brain
Rex-Mathes, M., Werner, S., Strutas, D., Griffith, L. S., Viebahn, C., Thelen, K., & Schmitz, B. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01305-0 · Cited by 46
O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1β
Resto, M., Kim, B., Fernandez, A. G., Abraham, B. J., Zhao, K., & Lewis, B. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751420 · Cited by 46
Jeon, B. T., Heo, R. W., Jeong, E. A., Yi, C., Lee, J. Y., Kim, K. E., Kim, H., & Roh, G. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.002 · Cited by 45
Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry
Wang, Y., Zhu, J., & Zhang, L. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01237 · Cited by 44
Akimoto, Y., Miura, Y., Toda, T., Wolfert, M. A., Wells, L., Boons, G., Hart, G. W., Endo, T., & Kawakami, H. (2011) · Clinical Proteomics · doi:10.1186/1559-0275-8-15 · Cited by 43
Self-citationGu, Y., Gao, J.-G., Han, C., Zhang, X., Liu, H., Ma, L., SUN, X., & Yu, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2269 · Cited by 43
O-GlcNAcylation and chromatin remodeling in mammals: an up-to-date overview
Leturcq, M., Lefebvre, T., & Vercoutter‐Edouart, A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160388 · Cited by 43
Zhang, Y., Qu, Y., Niu, T., Wang, H., & Liu, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.068 · Cited by 42
Ma, X., Liu, P., Yan, H., Sun, H., Liu, X., Zhou, F., Li, L., Chen, Y., Muthana, M. M., Chen, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063452 · Cited by 41
Analysis of Protein O‐GlcNAcylation by Mass Spectrometry
Ma, J., & Hart, G. W. (2017) · Current Protocols in Protein Science · doi:10.1002/cpps.24 · Cited by 40
Self-citationElevation of nucleocytoplasmic β-N-acetylglucosaminidase (O-GlcNAcase) activity in thyroid cancers
Krześlak, A. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000387 · Cited by 39
O‐GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1
Lim, K., & Chang, H.-I. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.007 · Cited by 39
OGT Mediated Histone H2B S112 GlcNAcylation Regulates DNA Damage Response
Wang, P., Peng, C., Liu, X., Liu, H., Chen, Y., Li, Z., Han, B., & Pei, H. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.07.002 · Cited by 38
Zhang, J., Lei, H., Chen, Y., Ma, Y.-T., Jiang, F., Tan, J., Zhang, Y., & Li, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.034 · Cited by 38
Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation
Ahmad, I., Hoessli, D. C., Walker‐Nasir, E., Rafik, S. M., Shakoori, A. R., & Nasir-ud-Din (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj401 · Cited by 37
O-GlcNAcylation of BMAL1 regulates circadian rhythms in NIH3T3 fibroblasts
Ma, Y.-T., Luo, H., Guan, W., Zhang, H., Chen, C., Wang, Z., & Li, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.043 · Cited by 37
Phoomak, C., Silsirivanit, A., Wongkham, C., Sripa, B., Puapairoj, A., & Wongkham, S. (2012) · PubMed · Cited by 37
The potential role of O-GlcNAc modification in cancer epigenetics
Forma, E., Jóźwiak, P., Bryś, M., & Krześlak, A. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0204-6 · Cited by 36
The tumor suppressor HIC1 (hypermethylated in cancer 1) is O ‐GlcNAc glycosylated
Lefebvre, T., Pinte, S., Guérardel, C., Deltour, S., Martin, N., Slomianny, M., Michalski, J., & Leprince, D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04316.x · Cited by 35
The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Constable, S., Wollaston‐Hayden, E. E., Teo, C. F., Morris, A., & Wells, L. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210790226465 · Cited by 35
Delporte, A., Zaeytijd, J. D., Storme, N. D., Azmi, A., Geelen, D., Smagghe, G. J., Guisez, Y., & Damme, E. J. M. V. (2014) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2014.07.021 · Cited by 35
Ahmad, I., Hoessli, D. C., Walker‐Nasir, E., Choudhary, M. I., Rafik, S. M., Shakoori, A. R., & Nasir‐ud‐Din (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20814 · Cited by 35
Din, N., Ahmad, I., Haq, I. U., Elahi, S., Hoessli, D. C., & Shakoori, A. R. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22436 · Cited by 34
O‐GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress
Ho, S., Wang, K., Whisenhunt, T. R., Huang, P. C., Zhu, X., Kudlow, J. E., & Paterson, A. J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.059 · Cited by 34
O-GlcNAcylation of Neuronal Proteins: Roles in Neuronal Functions and in Neurodegeneration
Lagerlöf, O., & Hart, G. W. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_16 · Cited by 32
Self-citationRegulation of Oct1/Pou2f1 transcription activity by O ‐GlcNAcylation
Kang, J., Shen, Z., Lim, J., Handa, H., Wells, L., & Tantin, D. R. (2013) · The FASEB Journal · doi:10.1096/fj.12-220897 · Cited by 32
Transcription factor Nrf1 is negatively regulated by its O‐GlcNAcylation status
Chen, J., Liu, X., Lu, F.-L., Liu, X., Ru, Y., Ren, Y., Yao, L., & Zhang, Y. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.030 · Cited by 31
Lozano, L., Lara‐Lemus, R., Zenteno, E., & Alvarado‐Vásquez, N. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.08.008 · Cited by 29
Modification of Topoisomerase I Activity by Glucose and by O-Glcnacylation of the Enzyme Protein
Noach, N., Segev, Y., Levi, I., Segal, S., & Priel, E. (2007) · Glycobiology · doi:10.1093/glycob/cwm105 · Cited by 29
Qiu, H., Liu, F., Tao, T., Zhang, D., Liu, X., Zhu, G., Xu, Z., Ni, R., & Shen, A. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22490 · Cited by 29
Activation of PPARγ negatively regulates O-GlcNAcylation of Sp1
Chung, S. S., Kim, J. H., Park, H. S., Choi, H. H., Lee, K. W., Cho, Y. M., Lee, H. K., & Park, K. S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.096 · Cited by 28
Nanashima, N., Asano, J., Hayakari, M., Nakamura, T., Nakano, H., Yamada, T., Shimizu, T., Akita, M., Yang, F., & Tsuchida, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509481200 · Cited by 26
O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity
Chen, R., Gong, P., Tao, T., Gao, Y., Shen, J., Yan, Y., Duan, C., Wang, J., & Liu, X. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0477-1 · Cited by 26
O-GlcNAc modification of radial glial vimentin filaments in the developing chick brain
FARACH, A. M., & Galileo, D. S. (2008) · Journal of Neurocytology · doi:10.1007/s11068-008-9036-5 · Cited by 23
Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes
Kang, M. J., Kim, C., Jeong, H., Cho, B.-K., Ryou, A. L., Hwang, D., Mook‐Jung, I., & Yi, E. C. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.56 · Cited by 22
McNulty, P. H. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00521.2006 · Cited by 21
Ning, X., Tao, T., Shen, J., Ji, Y., Xie, L., Wang, H., Liu, N., Xu, X., Sun, C. C., Zhang, D., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0391-y · Cited by 21
Ghirardello, M., Perrone, D., Chinaglia, N., Sádaba, D., Delso, I., Tejero, T., Marchesi, E., Fogagnolo, M., Rafie, K., van Aalten, D. M. F., et al. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801083 · Cited by 18
NOS1AP O-GlcNAc Modification Involved in Neuron Apoptosis Induced by Excitotoxicity
Zhu, L., Tao, T., Zhang, D., Liu, X., Ke, K., & Shen, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716560 · Cited by 16
Liu, S., Peng, B., Ma, J., Liu, Y. C., & Ng, S. Y. (1995) · Developmental Genetics · doi:10.1002/dvg.1020160303 · Cited by 14
Ha, C., & Lim, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.155 · Cited by 12
Bork, K., Kannicht, C., Nöhring, S., Reutter, W. G., Weidemann, W., Hart, G. W., & Horstkorte, R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21526 · Cited by 11
Self-citationThe sweet tooth of the circadian clock
Fu, M., & Yang, X. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160183 · Cited by 11
Transcription: another mark in the tail
Svejstrup, J. Q. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.154 · Cited by 9
Azuma, Y., Miura, K., Higai, K., & Matsumoto, K. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2284 · Cited by 8
O-GlcNAcylation of a circadian clock protein: dPER taking its sweet time: Figure 1.Preprint
Diernfellner, A. C. R., & Brunner, M. (2012) · Genes & Development · doi:10.1101/gad.188524.112 · Cited by 4
Sugarcoating Polycomb Repression
Verrijzer, C. P. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.027 · Cited by 2
Cited by
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,309
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
Metadata
- Authors
- Hart, G. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 294
- Issue
- 7
- Pages
- 2211-2231
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2911143204
- Cited by
- 345
- References
- 333
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.